History of Cannabis and Its Preparations in Saga, Science, and Sobriquet

Cited in:

CrossRef

This article has been cited by:

1. 1
   ALSUntangled No. 16: Cannabis, Amyotrophic Lateral Sclerosis, 2012, 13, 4, 400

   CrossRef

2. You have free access to this content2
   EM Rock, D Bolognini, CL Limebeer, MG Cascio, S Anavi-Goffer, PJ Fletcher, R Mechoulam, RG Pertwee, LA Parker, Cannabidiol, a non-psychotropic component of cannabis, attenuates vomiting and nausea-like behaviour via indirect agonism of 5-HT_1A somatodendritic autoreceptors in the dorsal raphe nucleus, British Journal of Pharmacology, 2012, 165, 8

   Direct Link:

   • Abstract
   • Full Article (HTML)
   • PDF(1145K)
   • References
3. You have free access to this content3
   Mauro Maccarrone, Steve PH Alexander, Cannabinoid research in the 2010s, British Journal of Pharmacology, 2012, 165, 8

   Direct Link:

   • Abstract
   • Full Article (HTML)
   • PDF(120K)
   • References
4. 4
   Philippe Lucas, It can't hurt to ask; a patient-centered quality of service assessment of health canada's medical cannabis policy and program, Harm Reduction Journal, 2012, 9, 1, 2

   CrossRef

5. 5
   Andrew J. Hill, Claire M. Williams, Benjamin J. Whalley, Gary J. Stephens, Phytocannabinoids as novel therapeutic agents in CNS disorders, Pharmacology & Therapeutics, 2012, 133, 1, 79

   CrossRef

6. 6
   Mark Collen, Prescribing cannabis for harm reduction, Harm Reduction Journal, 2012, 9, 1, 1

   CrossRef

7. 7
   Philip Robson, Abuse potential and psychoactive effects of δ-9-tetrahydrocannabinol and cannabidiol oromucosal spray (Sativex), a new cannabinoid medicine, Expert Opinion on Drug Safety, 2011, 10, 5, 675

   CrossRef

8. You have free access to this content8
   Ethan B Russo, Taming THC: potential cannabis synergy and phytocannabinoid-terpenoid entourage effects, British Journal of Pharmacology, 2011, 163, 7

   Direct Link:

   • Abstract
   • Full Article (HTML)
   • PDF(2223K)
   • References
9. 9
   K. Zavitsanou, H. Wang, V.S. Dalton, V. Nguyen, Cannabinoid administration increases 5HT1A receptor binding and mRNA expression in the hippocampus of adult but not adolescent rats, Neuroscience, 2010, 169, 1, 315

   CrossRef

10. 10
    Justin Fischedick, Frank Van Der Kooy, Robert Verpoorte, Cannabinoid Receptor 1 Binding Activity and Quantitative Analysis of Cannabis sativa L. Smoke and Vapor, CHEMICAL & PHARMACEUTICAL BULLETIN, 2010, 58, 2, 201

    CrossRef

11. 11
    Justin Thomas Fischedick, Arno Hazekamp, Tjalling Erkelens, Young Hae Choi, Rob Verpoorte, Metabolic fingerprinting of Cannabis sativa L., cannabinoids and terpenoids for chemotaxonomic and drug standardization purposes, Phytochemistry, 2010, 71, 17-18, 2058

    CrossRef

12. 12
    Lorène Girault, Cannabis et cannabinoïdes en médecine, Actualités Pharmaceutiques, 2009, 48, 486, 19

    CrossRef

13. 13
    Christian Giroud, Marc Bollmann, Aurélien Thomas, Patrice Mangin, Bernard Favrat, Consommation de cannabis: quels sont les risques ?, Annales de Toxicologie Analytique, 2009, 20, 4, 183

    CrossRef

14. 14
    Viviana Trezza, Vincenzo Cuomo, Louk J.M.J. Vanderschuren, Cannabis and the developing brain: Insights from behavior, European Journal of Pharmacology, 2008, 585, 2-3, 441

    CrossRef

15. 15
    Eric A Horne, Nephi Stella, The ins and outs of endocannabinoid signaling in healthy and diseased brain, Future Lipidology, 2008, 3, 4, 435

    CrossRef

16. 16
    Kees Boer, Regine PM Steegers-Theunissen, Eric AP Steegers, Textbook of Periconceptional Medicine, 2008,

    CrossRef

17. 17
    Ethan B. Russo, History of Cannabis and Its Preparations in Saga, Science, and Sobriquet, ChemInform, 2007, 38, 47

    Direct Link:

    • Abstract
    • Full Article (HTML)
    • PDF(11K)
    • References